Zhaolu Zhu

Title: Zhaolu Zhu - Innovator in Pharmaceutical Composition

Introduction

Zhaolu Zhu, a distinguished inventor based in Beijing, China, has made significant contributions to the field of pharmaceuticals. With a patent to his name, he has demonstrated a commitment to enhancing drug delivery systems, ultimately improving patient outcomes.

Latest Patents

Zhu's notable patent is for a "Pregabalin sustained release composition and method for preparing the same." This innovative composition includes an active ingredient, matrix-forming agent, swelling agent, gelling agent, and may optionally contain a filler. The unique aspect of this formulation is its ability to rapidly swell in volume when it comes into contact with aqueous mediums. This characteristic allows the composition to exceed the diameter of the human gastric pyloric (13 mm), thereby prolonging gastric emptying time. As a result, this increases the retention time of pregabalin in the stomach, enhancing its absorption in the small intestine and ascending colon. Furthermore, Zhu's formulation delivers a sustained release of the active ingredient for up to 24 hours, permitting once-a-day administration. This advancement reduces the number of doses required and improves patient compliance.

Career Highlights

Zhaolu Zhu is currently affiliated with Beijing Tide Pharmaceutical Co., Ltd., where he leverages his expertise to develop innovative pharmaceutical solutions. His work exemplifies the intersection of science and patient care, highlighting the vital role of inventors in medical advancements.

Collaborations

Zhu collaborates with several talented professionals, including Yun Wu and Di Lu. Their combined efforts contribute to a productive environment that fosters innovation and excellence in pharmaceutical research and development.

Conclusion

Zhaolu Zhu's achievements in creating a sustained release composition for pregabalin underscore his contributions to pharmaceutical innovation. Through his dedication and collaboration with his peers, he continues to impact the industry positively, enhancing drug delivery systems for better patient adherence and outcomes.